Clinical Trials Directory

Trials / Completed

CompletedNCT02814357

To Test the Effect of Selected Fibres and Flours in Flat Bread on Post-Prandial Blood Glucose and Insulin Responses in Healthy Indian Population

To Evaluate the Effect of 4 Different Flour Compositions of Selected Fibres and Flours, on Post-prandial Plasma Glucose (PPG) and Serum Insulin Levels in Normal Indian Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Unilever R&D · Industry
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Double-blind, randomized, controlled, cross-over design with 3 test products and one control product. To evaluate the effect of 4 different flour compositions (guar gum 2% and 4%, chickpea flour 15% and barley flour 2% and 5%) of selected fibres and flours, on post-prandial plasma (PPG) and serum insulin levels in healthy Indian subjects, after the consumption of flat bread made from 100 gram of flour compositions.

Conditions

Interventions

TypeNameDescription
OTHERControl (market standard)
OTHERwheat flour
OTHERchickpea flour
OTHERguar gum
OTHERbarley

Timeline

Start date
2011-07-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2016-06-27
Last updated
2016-07-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02814357. Inclusion in this directory is not an endorsement.